Latest News from: Atlantic Health System

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 29
Newswise: Advanced Lung Cancer Screening Available at Atlantic Health System

Advanced Lung Cancer Screening Available at Atlantic Health System

Atlantic Health System

The Atlantic Health System lung cancer test uses low-dose computed tomography (LDCT) that only takes a few minutes to complete and may identify lung cancer at earlier, more curable stages. When compared to chest X-rays used in early detection, the LDCT screening reduces lung cancer deaths in high-risk individuals by 20 percent. The screening test is covered by Medicare and most commercial insurance. Approximately 2% of screenings show early findings of lung cancer.

Channels: Cancer, Women's Health, Respiratory Diseases and Disorders,

Released:
20-Nov-2019 6:05 AM EST
Newswise: Atlantic Health System Cancer Care Enrolling Patients in Innovative Pancreatic Cancer Clinical Trials

Atlantic Health System Cancer Care Enrolling Patients in Innovative Pancreatic Cancer Clinical Trials

Atlantic Health System

November is national Pancreatic Cancer Awareness month. This year alone, more than 56,000 Americans will be diagnosed with pancreatic cancer. Pancreatic tumors are particularly aggressive and hard to treat "due to a mutational profile that makes it resistant to therapies that work better for other tumor types," explains Angela Alistar, MD, medical director of GI oncology at Morristown Medical Center. Dr. Alistar, an internationally known expert on pancreatic cancer, is now enrolling patients in five clinical trials aimed at pancreatic cancer.

Channels: All Journal News, Cancer, Clinical Trials, Digestive Disorders, Healthcare,

Released:
30-Oct-2019 5:50 AM EDT
Feature
Newswise: CAR T Cell Clinical Trial for Non-Hodgkin’s Lymphoma Begins at Atlantic Health System

CAR T Cell Clinical Trial for Non-Hodgkin’s Lymphoma Begins at Atlantic Health System

Atlantic Health System

Atlantic Health System is treating patients in a new Phase 2 clinical trial of CAR T-cell therapy at Morristown Medical Center. A select number of sites across the U.S. are involved in this study, which is done on an outpatient basis. The study is sponsored by Juno Therapeutics, Inc. The study’s principal investigator, Mohamad Cherry, MD, medical director of hematology for Atlantic Health System Cancer Care, is a nationally known expert at treating and researching blood-related cancers such as lymphoma, leukemia and myeloma. Dr. Cherry is triple board-certified in internal medicine, hematology and medical oncology

Channels: Cancer, Clinical Trials, Immunology, Blood,

Released:
25-Oct-2019 9:30 AM EDT
Feature
AtlanticHealthSystem_A_Color_CMYK_150.jpg

Overlook Medical Center Offers “Next Generation” 3-D Technology to Improve Prostate Cancer Diagnosis

Atlantic Health System

Atlantic Health System Cancer Care at Overlook Medical Center is now offering a highly advanced technology that will enhance the ability of physicians to diagnose, stage and treat prostate cancer. The UroNav Fusion Biopsy System fuses pre-biopsy magnetic resonance imaging (MRI) images of the prostate with ultrasound-guided 3-D images in real time, allowing for excellent imaging of the prostate and any abnormal changes (lesions) that may or may not be cancerous.

Channels: Cancer, Men's Health,

Released:
23-Sep-2019 1:05 PM EDT
Feature
AtlanticHealthSystem_A_Color_CMYK_150.jpg

Study to Evaluate Best Medical Management for Stroke Caused by Intracerebral Hemorrhage

Atlantic Health System

The MIND study compares the safety and efficacy of a neuro-evacuation device to best medical management in evacuating intracerebral hemorrhage - a life-threatening kind of stroke which occurs when a diseased blood vessel within the brain bursts.

Channels: Neuro, Surgery,

Released:
10-Sep-2019 7:05 AM EDT
Feature Expert
Newswise: New Jersey’s First National Cancer Institute Community Oncology Research Program (NCORP) Awarded to Atlantic Health Cancer Consortium

New Jersey’s First National Cancer Institute Community Oncology Research Program (NCORP) Awarded to Atlantic Health Cancer Consortium

Atlantic Health System

The National Cancer Institute (NCI) has designated Atlantic Health System as a National Community Oncology Research Program (NCORP) site of the Atlantic Health Cancer Consortium (AHCC). As New Jersey’s first and only NCORP, AHCC will help develop and implement NCI cancer prevention, screening, care delivery and treatment studies with leading health care systems across the state.

Channels: Cancer,

Released:
21-Aug-2019 8:45 AM EDT
Feature
Newswise: First Surgery with ROSA® Brain Robot in New Jersey 
Performed at Overlook Medical Center

First Surgery with ROSA® Brain Robot in New Jersey Performed at Overlook Medical Center

Atlantic Health System

The first surgery in New Jersey using the ROSA Brain robot was performed by Ronald Benitez, MD, chief of endovascular neurosurgery, Overlook Medical Center. Conventional brain surgery for epilepsy requires a craniotomy. Using ROSA Brain, surgeons make tiny holes in the skull through which they insert electrodes to record brain activity and help pinpoint exactly which part of the brain is responsible for seizures. The robot can also assist in deep brain stimulation, trans-nasal and ventricular endoscopy, and brain biopsies.

Channels: Clinical Trials, Epilepsy, Neuro, Surgery,

Released:
29-Jul-2019 4:00 AM EDT
Announcement

New Jersey Hospital Helps Pioneer Unique Personalized Immunotherapy for Metastatic Melanoma

Atlantic Health System

Atlantic Melanoma Center is among the nation’s leading cancer programs participating in the clinical trials of a new type of personalized immunotherapy known as TIL (tumor infiltrating lymphocyte) therapy, in which the patient’s own immune system cells are removed from his/her tumor, treated with an immune booster and then infused back into the patient, along with a medication that stimulates the immune system. Iovance Biotherapeutics is developing TIL therapy for soild tumors and is currently conducting the pivotal study innovaTIL-01 in patients with metastatic melanoma. Atlantic Melanoma Center at Morristown Medical Center is the only site in New Jersey to treat patients with this unique experimental therapy.

Channels: Cancer, Healthcare,

Released:
14-Jun-2019 12:00 AM EDT
Feature Expert
Newswise: Atlantic Health System Physicians Co-Author Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

Atlantic Health System Physicians Co-Author Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

Atlantic Health System

Studies to be presented at the ASCO meeting are co-authored by research oncologists Eric Whitman, MD; Missak Haigentz, MD; and Angela Alistar, MD. Their ASCO studies include: two separate studies looking at TILS therapy and Keytruda for advanced melanoma; immunotherapy for metastatic head and neck cancer; treatment for recurrent Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma; and a combination of CPI-613 -- a new type of medication, pioneered by Dr. Alistar, known as an altered energy metabolism drug -- with 5-FU in treating metastatic colorectal cancer.

Channels: Cancer, Cell Biology, Clinical Trials, Dermatology, Healthcare, Immunology,

Released:
31-May-2019 2:00 PM EDT
Feature

Showing results

110 of 29

Chat now!
0.48514